GENERATION BIO CO. - COMMON STOCK

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

06 يناير 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results

06 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

22 أكتوبر 2024 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

12 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Generation Bio Reports Second Quarter 2024 Financial Results

07 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

06 أغسطس 2024 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

14 يونيو 2024 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

13 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

09 مايو 2024 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

22 أبريل 2024 17:31:01 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

02 أبريل 2024 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

06 مارس 2024 16:20:00 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

27 فبراير 2024 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 يناير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

29 نوفمبر 2023 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

09 نوفمبر 2023 16:15:00 بحسب Nasdaq GlobeNewswire

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

26 أكتوبر 2023 06:59:00 بحسب Nasdaq GlobeNewswire

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

18 أكتوبر 2023 06:59:16 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

19 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference 

03 أغسطس 2023 07:30:00 بحسب Nasdaq GlobeNewswire